New Treatment Modalities in Inflammatory Bowel Diseases
dc.contributor.advisor | Palatka, Károly | |
dc.contributor.advisordept | Debreceni Egyetem::Általános Orvostudományi Kar::Belgyógyászati Intézet | hu_HU |
dc.contributor.author | Udeh, Uba Chinyere | |
dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
dc.contributor.opponent | Nemes, Éva | |
dc.contributor.opponent | Kovács, György | |
dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Gyermekgyógyászati Intézet | hu_HU |
dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Belgyógyászati Intézet | hu_HU |
dc.date.accessioned | 2020-02-04T11:48:47Z | |
dc.date.available | 2020-02-04T11:48:47Z | |
dc.date.created | 2019-08-22 | |
dc.description.abstract | IBD, including Crohn's disease and Ulcerative Colitis is a chronic inflammatory disorder. This thesis focuses on newer, more effective and specific treatments that improve the life of the patient while limiting side-effects. | hu_HU |
dc.description.course | általános orvos | hu_HU |
dc.description.courselang | angol | hu_HU |
dc.description.coursespec | Orvosbiológia-farmakológia | hu_HU |
dc.description.degree | egységes, osztatlan | hu_HU |
dc.format.extent | 47 | hu_HU |
dc.identifier.uri | http://hdl.handle.net/2437/280311 | |
dc.language.iso | en | hu_HU |
dc.subject | IBD | hu_HU |
dc.subject | TNF | hu_HU |
dc.subject | Crohn's disease | hu_HU |
dc.subject | Ulcerative Colitis | hu_HU |
dc.subject | Intergrins | hu_HU |
dc.subject | vedolizumab | hu_HU |
dc.subject | Jak-stat | hu_HU |
dc.subject | smad-7 | hu_HU |
dc.subject | tofacitinib | hu_HU |
dc.subject | small molecules | hu_HU |
dc.subject | biologics | hu_HU |
dc.subject | infliximab | hu_HU |
dc.subject | golimumab | hu_HU |
dc.subject | adalimumab | hu_HU |
dc.subject | sphingosine-1-phosphate | hu_HU |
dc.subject | certolizumab | hu_HU |
dc.subject.dspace | DEENK Témalista::Orvostudomány | hu_HU |
dc.title | New Treatment Modalities in Inflammatory Bowel Diseases | hu_HU |